EcoDrugPlus

Apelin Receptor

Ensembl ID : ENSLACG00000005190
Gene Symbol: APLNR
4 Cross references
171 Possible Orthologues:

Aph-1 Homolog B, Gamma-Secretase Subunit

Ensembl ID : ENSLACG00000012093
Gene Symbol: APH1B
4 Cross references
184 Possible Orthologues:

Apurinic/apyrimidinic Endodeoxyribonuclease 1

Ensembl ID : ENSLACG00000008617
Gene Symbol: APEX1
4 Cross references
212 Possible Orthologues:

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSLACG00000007095
Gene Symbol: ALOX5
4 Cross references
219 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSLACG00000014523
Gene Symbol: AVPR1A
4 Cross references
264 Possible Orthologues:

Arginine Vasopressin Receptor 1b

Ensembl ID : ENSLACG00000013680
Gene Symbol: AVPR1B
4 Cross references
135 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSLACG00000014898
Gene Symbol: AVPR2
4 Cross references
231 Possible Orthologues:

Aryl Hydrocarbon Receptor

Ensembl ID : ENSLACG00000002803
Gene Symbol: AHR
4 Cross references
154 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 2-Like

Ensembl ID : ENSLACG00000000648
Gene Symbol: LOC102351936
3 Cross references
185 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSLACG00000016221
Gene Symbol: AURKA
3 Cross references
234 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSLACG00000001099
Gene Symbol: AURKB
1 Cross references
203 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSLACG00000018288
Gene Symbol: BACE1
4 Cross references
218 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).